Acute idiopathic pancreatitis is associated with more aggressive disease course in Crohn's disease but not in ulcerative colitis.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
22 May 2023
Historique:
received: 08 02 2023
accepted: 27 04 2023
medline: 24 5 2023
pubmed: 23 5 2023
entrez: 22 5 2023
Statut: epublish

Résumé

Patients with inflammatory bowel disease (IBD), whether Crohn's disease (CD) or ulcerative colitis (UC), have an increased risk of acute pancreatitis. The prognostic value of diagnosing acute idiopathic pancreatitis in patients with IBD is not well understood. A retrospective review of 56 patients with IBD and acute pancreatitis was conducted in a tertiary center from 2011 to 2020. Aggressive disease course was defined as (i)biologic change, (ii)biologic dose escalation, or (iii)IBD-related surgeries occurring within 1 year of acute pancreatitis diagnosis. Logistic regression modelling identified associations between covariates and an aggressive disease course. Baseline characteristics between idiopathic pancreatitis and other causes of acute pancreatitis, in both CD and UC cohorts, were similar. Idiopathic pancreatitis was significantly associated with an aggressive disease course in CD (P = 0.04). No confounding factors were associated with an aggressive disease course in CD. Idiopathic pancreatitis, however, was not associated with an aggressive disease course in UC (P = 0.35). The diagnosis of acute idiopathic pancreatitis may provide a prognostic indicator of a more severe disease course in CD. No such association appears to exist with UC. To the best of our knowledge, this is the first study that identifies an association and possible prognostic value between idiopathic pancreatitis and a more severe disease course in CD. More studies with a larger sample size are needed to validate these findings, further define idiopathic pancreatitis as an extraintestinal manifestation of IBD and elucidate a clinical strategy to optimize care in patients with aggressive CD and idiopathic pancreatitis.

Identifiants

pubmed: 37217857
doi: 10.1186/s12876-023-02790-8
pii: 10.1186/s12876-023-02790-8
pmc: PMC10201786
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171

Informations de copyright

© 2023. The Author(s).

Références

Am J Gastroenterol. 2000 Oct;95(10):3004-5
pubmed: 11051402
Mayo Clin Proc. 2006 Nov;81(11):1462-71
pubmed: 17120402
Aliment Pharmacol Ther. 2008 Sep 1;28(5):623-8
pubmed: 18513380
Pancreas. 2020 Oct;49(9):1174-1181
pubmed: 32898001
Eur J Clin Pharmacol. 2002 Jul;58(4):275-83
pubmed: 12136374
Pancreatology. 2017 Nov - Dec;17(6):867-874
pubmed: 28935288
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
J Clin Epidemiol. 1995 Dec;48(12):1495-501
pubmed: 8543963
Pancreas. 2013 Jan;42(1):1-5
pubmed: 22750972
Gastroenterol Res Pract. 2020 Aug 03;2020:7305241
pubmed: 32831829
Gut. 2007 Sep;56(9):1321-2
pubmed: 17698871
J Clin Gastroenterol. 1993 Dec;17(4):286-91
pubmed: 8308212
Am J Gastroenterol. 2014 Nov;109(11):1728-38
pubmed: 25223575
Curr Gastroenterol Rep. 2012 Apr;14(2):131-8
pubmed: 22314811
Scand J Gastroenterol. 1999 Feb;34(2):199-201
pubmed: 10192201
Inflamm Bowel Dis. 2015 Aug;21(8):1982-92
pubmed: 26154136
Nat Rev Gastroenterol Hepatol. 2012 Oct;9(10):599-608
pubmed: 22907164
Dig Dis Sci. 1985 Dec;30(12):1121-6
pubmed: 2866072
Antimicrob Agents Chemother. 2013 May;57(5):2016-25
pubmed: 23403424
Am J Gastroenterol. 2004 May;99(5):884-8
pubmed: 15128355
J Clin Epidemiol. 1995 Dec;48(12):1503-10
pubmed: 8543964
Rambam Maimonides Med J. 2021 Jul 20;12(3):
pubmed: 34270401
BMJ. 2013 Nov 14;347:f6633
pubmed: 24231178
Intern Med. 2003 Jan;42(1):125-6
pubmed: 12583634
J Gastrointestin Liver Dis. 2021 Sep 21;30(3):346-357
pubmed: 34375380
World J Gastroenterol. 2014 Sep 14;20(34):12269-76
pubmed: 25232261
Clin Gastroenterol Hepatol. 2019 Jan;17(2):290-295
pubmed: 30144522
Gastroenterol Hepatol (N Y). 2011 Oct;7(10):652-9
pubmed: 22298958
Gut. 2008 Apr;57(4):463-7
pubmed: 17989107
J Gastroenterol. 2018 Mar;53(3):305-353
pubmed: 29429045
J Crohns Colitis. 2016 Jan;10(1):95-104
pubmed: 26351384
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487

Auteurs

Karim T Osman (KT)

Department of Internal Medicine, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA. ktarek.osman@gmail.com.
Department of Internal Medicine, Lahey Hospital and Medical Center, Beth Israel Lahey Clinic, Burlington, 01803, MA, USA. ktarek.osman@gmail.com.

Asahi Hoque (A)

Department of Internal Medicine, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Ravi Teja Pasam (RT)

Department of Internal Medicine, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Adel Farhoud (A)

Department of Gastroenterology and Hepatology, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Ahmed Abdelfattah (A)

Department of Gastroenterology and Hepatology, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Vishant Ramadorai (V)

Department of Gastroenterology and Hepatology, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Khadija Chaudrey (K)

Department of Gastroenterology and Hepatology, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Randall Pellish (R)

Department of Gastroenterology and Hepatology, Lahey Hospital and Medical Center, Tufts Medical School, Burlington, 01805, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH